| SS/JrSeac |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
126 days
| 5 |
|
6.3 |
mm |
0.25 |
0.57 |
transthoracic echocardiography |
0.0 |
0 |
|
68581 |
733 |
| SS/JrSeac |
myocardial flow rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then controlled oxygen content Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
coronary blood flow trait |
not specified |
126 days
| 5 |
|
2.84 |
ml/min |
0.25 |
0.57 |
isolated perfused heart method |
0.0 |
0 |
K1, myocardial flow rate |
68597 |
733 |
| SS/JrSeac |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
arterial blood pressure trait |
not specified |
77 days
| 5 |
|
125.0 |
mmHg |
9.84 |
22.0 |
tail cuff plethysmography |
0.0 |
0 |
|
67248 |
733 |
| SS/JrSeac |
body weight |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
body mass |
not specified |
126 days
| 5 |
|
303.0 |
g |
14.31 |
32.0 |
body weighing method |
0.0 |
0 |
|
67255 |
733 |
| SS/JrSeac |
heart left ventricle end-systolic posterior wall thickness |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
126 days
| 5 |
|
1.2 |
mm |
0.11 |
0.24 |
transthoracic echocardiography |
0.0 |
0 |
End-systole posterior wall thickening |
68586 |
733 |
| SS/JrSeac |
heart rate |
controlled sodium content diet (8 %) (for 84 days) then controlled oxygen content Kreb's solution perfusate |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart pumping trait |
not specified |
77 days
| 5 |
|
268.0 |
beats/min |
45.62 |
102.0 |
isolated perfused heart method |
0.0 |
0 |
|
68592 |
733 |
| SS/JrSeac |
heart left ventricle wet weight |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle mass |
not specified |
126 days
| 5 |
|
2.0 |
g |
0.18 |
0.4 |
post excision weight measurement |
0.0 |
0 |
|
67260 |
733 |
| SS/JrSeac |
myocardial clearance rate |
controlled sodium content diet (8 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart muscle physiology trait |
not specified |
77 days
| 5 |
|
0.0 |
/min |
0.0 |
0.0 |
isolated perfused heart method |
0.0 |
0 |
K2, myocardial clearance rate |
68600 |
733 |
| SS/JrSeac |
heart left ventricle relative wall thickness |
controlled sodium content diet (0.3 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
126 days
| 5 |
RWT = 2 × PWT/EDD |
39.0 |
% |
4.92 |
11.0 |
transthoracic echocardiography |
0.0 |
0 |
|
68589 |
733 |
| SS/JrSeac |
systolic blood pressure |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
arterial blood pressure trait |
not specified |
77 days
| 5 |
|
246.0 |
mmHg |
10.73 |
24.0 |
tail cuff plethysmography |
0.0 |
0 |
|
67249 |
733 |
| SS/JrSeac |
body weight |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
body mass |
not specified |
126 days
| 5 |
|
273.0 |
g |
6.26 |
14.0 |
body weighing method |
0.0 |
0 |
|
67256 |
733 |
| SS/JrSeac |
heart left ventricle wet weight |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle mass |
not specified |
77 days
| 5 |
|
1.0 |
g |
0.09 |
0.2 |
post excision weight measurement |
0.0 |
0 |
|
67257 |
733 |
| SS/JrSeac |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
77 days
| 5 |
FS=(EDD−ESD)/EDD |
46.0 |
% |
2.91 |
6.5 |
transthoracic echocardiography |
0.0 |
0 |
|
68575 |
733 |
| SS/JrSeac |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
77 days
| 5 |
|
5.26 |
mm |
0.49 |
1.1 |
transthoracic echocardiography |
0.0 |
0 |
|
68580 |
733 |
| SS/JrSeac |
heart left ventricle relative wall thickness |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
77 days
| 5 |
RWT = 2 × PWT/EDD |
44.0 |
% |
7.16 |
16.0 |
transthoracic echocardiography |
0.0 |
0 |
|
68587 |
733 |
| SS/JrSeac |
myocardial flow rate |
controlled sodium content diet (8 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then controlled oxygen content Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
coronary blood flow trait |
not specified |
126 days
| 5 |
|
1.91 |
ml/min |
0.4 |
0.9 |
isolated perfused heart method |
0.0 |
0 |
K1, myocardial flow rate |
68598 |
733 |
| SS/JrSeac |
myocardial clearance rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart muscle physiology trait |
not specified |
77 days
| 5 |
|
0.0 |
/min |
0.0 |
0.0 |
isolated perfused heart method |
0.0 |
0 |
K2, myocardial clearance rate |
68599 |
733 |
| SS/JrSeac |
heart left ventricle wet weight |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle mass |
not specified |
77 days
| 5 |
|
1.4 |
g |
0.13 |
0.3 |
post excision weight measurement |
0.0 |
0 |
|
67258 |
733 |
| SS/JrSeac |
heart left ventricle fractional shortening |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
77 days
| 5 |
FS=(EDD−ESD)/EDD |
57.0 |
% |
2.64 |
5.9 |
transthoracic echocardiography |
0.0 |
0 |
|
68576 |
733 |
| SS/JrSeac |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
126 days
| 5 |
|
8.9 |
mm |
0.93 |
2.07 |
transthoracic echocardiography |
0.0 |
0 |
|
68582 |
733 |
| SS/JrSeac |
body weight |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
body mass |
not specified |
77 days
| 5 |
|
236.0 |
g |
7.16 |
16.0 |
body weighing method |
0.0 |
0 |
|
67254 |
733 |
| SS/JrSeac |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
126 days
| 5 |
FS=(EDD−ESD)/EDD |
44.0 |
% |
2.91 |
6.5 |
transthoracic echocardiography |
0.0 |
0 |
|
68577 |
733 |
| SS/JrSeac |
heart left ventricle end-systolic posterior wall thickness |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
77 days
| 5 |
|
2.1 |
mm |
0.21 |
0.46 |
transthoracic echocardiography |
0.0 |
0 |
End-systole posterior wall thickening |
68584 |
733 |
| SS/JrSeac |
heart left ventricle end-systolic posterior wall thickness |
controlled sodium content diet (0.3 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
126 days
| 5 |
|
1.24 |
mm |
0.16 |
0.36 |
transthoracic echocardiography |
0.0 |
0 |
End-systole posterior wall thickening |
68585 |
733 |
| SS/JrSeac |
heart left ventricle relative wall thickness |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
77 days
| 5 |
RWT = 2 × PWT/EDD |
86.0 |
% |
16.55 |
37.0 |
transthoracic echocardiography |
0.0 |
0 |
|
68588 |
733 |
| SS/JrSeac |
heart rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart pumping trait |
not specified |
77 days
| 5 |
|
264.0 |
beats/min |
37.12 |
83.0 |
isolated perfused heart method |
0.0 |
0 |
|
68591 |
733 |
| SS/JrSeac |
heart rate |
controlled sodium content diet (0.3 %) (for 84 days) then controlled oxygen content Kreb's solution perfusate |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart pumping trait |
not specified |
126 days
| 5 |
|
262.0 |
beats/min |
40.7 |
91.0 |
isolated perfused heart method |
0.0 |
0 |
|
68593 |
733 |
| SS/JrSeac |
heart rate |
controlled sodium content diet (8 %) (for 84 days) then controlled oxygen content Kreb's solution perfusate |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart pumping trait |
not specified |
126 days
| 5 |
|
284.0 |
beats/min |
58.58 |
131.0 |
isolated perfused heart method |
0.0 |
0 |
|
68594 |
733 |
| SS/JrSeac |
myocardial flow rate |
controlled sodium content diet (8 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then controlled oxygen content Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
coronary blood flow trait |
not specified |
77 days
| 5 |
|
2.36 |
ml/min |
0.48 |
1.07 |
isolated perfused heart method |
0.0 |
0 |
K1, myocardial flow rate |
68596 |
733 |
| SS/JrSeac |
myocardial clearance rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart muscle physiology trait |
not specified |
126 days
| 5 |
|
0.0 |
/min |
0.0 |
0.0 |
isolated perfused heart method |
0.0 |
0 |
K2, myocardial clearance rate |
68601 |
733 |
| SS/JrSeac |
myocardial clearance rate |
controlled sodium content diet (8 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart muscle physiology trait |
not specified |
126 days
| 5 |
|
0.0 |
/min |
0.0 |
0.0 |
isolated perfused heart method |
0.0 |
0 |
K2, myocardial clearance rate |
68602 |
733 |
| SS/JrSeac |
systolic blood pressure |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
arterial blood pressure trait |
not specified |
126 days
| 5 |
|
249.0 |
mmHg |
18.34 |
41.0 |
tail cuff plethysmography |
0.0 |
0 |
|
67251 |
733 |
| SS/JrSeac |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
77 days
| 5 |
|
5.82 |
mm |
0.3 |
0.66 |
transthoracic echocardiography |
0.0 |
0 |
|
68579 |
733 |
| SS/JrSeac |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
arterial blood pressure trait |
not specified |
126 days
| 5 |
|
117.0 |
mmHg |
11.18 |
25.0 |
tail cuff plethysmography |
0.0 |
0 |
|
67250 |
733 |
| SS/JrSeac |
body weight |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
body mass |
not specified |
77 days
| 5 |
|
247.0 |
g |
7.6 |
17.0 |
body weighing method |
0.0 |
0 |
|
67253 |
733 |
| SS/JrSeac |
heart left ventricle wet weight |
controlled sodium content diet (0.3 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle mass |
not specified |
126 days
| 5 |
|
1.1 |
g |
0.09 |
0.2 |
post excision weight measurement |
0.0 |
0 |
|
67259 |
733 |
| SS/JrSeac |
heart left ventricle fractional shortening |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
126 days
| 5 |
FS=(EDD−ESD)/EDD |
23.0 |
% |
2.59 |
5.8 |
transthoracic echocardiography |
0.0 |
0 |
|
68578 |
733 |
| SS/JrSeac |
heart left ventricle end-systolic posterior wall thickness |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
77 days
| 5 |
|
1.32 |
mm |
0.15 |
0.34 |
transthoracic echocardiography |
0.0 |
0 |
End-systole posterior wall thickening |
68583 |
733 |
| SS/JrSeac |
heart left ventricle relative wall thickness |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
126 days
| 5 |
RWT = 2 × PWT/EDD |
29.0 |
% |
5.81 |
13.0 |
transthoracic echocardiography |
0.0 |
0 |
|
68590 |
733 |
| SS/JrSeac |
myocardial flow rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then controlled oxygen content Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
coronary blood flow trait |
not specified |
77 days
| 5 |
|
2.59 |
ml/min |
0.13 |
0.28 |
isolated perfused heart method |
0.0 |
0 |
K1, myocardial flow rate |
68595 |
733 |
